Sebastopol, CA, United States of America

James T Kealey

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Baymedica, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James T Kealey. Retrieved from https://idiyas.com/inventor/james-t-kealey-9kmidc49

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: James T Kealey: Innovator in Cannabinoid Research

Introduction

James T Kealey is a notable inventor based in Sebastopol, California. He has made significant contributions to the field of cannabinoid research, particularly through his innovative patent.

Latest Patents

James T Kealey holds a patent for "Cannabinoid Analogs and Methods for Their Preparation." This patent reflects his expertise and dedication to advancing cannabinoid science.

Career Highlights

Kealey is associated with Baymedica, Inc., where he applies his knowledge and skills to further research and development in the cannabinoid sector. His work has the potential to impact various applications in medicine and wellness.

Collaborations

James T Kealey collaborates with Philip J Barr, enhancing the research efforts at Baymedica, Inc. Their partnership exemplifies the importance of teamwork in driving innovation.

Conclusion

James T Kealey is a prominent figure in cannabinoid research, with a patent that showcases his innovative spirit and contributions to the field. His work at Baymedica, Inc. continues to pave the way for advancements in cannabinoid applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…